Close
Nordic 9Nordic 9

Corundum Systems Biology (investor - Others)

Japan csb.co.jp
See something wrong or missing? Let us know
Offices:Tokyo
Average round investment:20.75M USD
Average number per year:1.0
Distribution: 2026 (1)2023 (1)
Portfolio companies: United Kingdom Sequential SkinDenmark Freya Biosciences
Mostly invests in: United Kingdom United Kingdom (1) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Corundum Systems Biology

Name Criteria
United States Calyx
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Ecommerce, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Dara Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Ecommerce, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Kathaka
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Ecommerce, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Roquette Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Apater Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Ecommerce, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Henkel X
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Ecommerce, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Firebolt Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Fred Moll
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Ecommerce, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Cross Border Impact Ventures
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Ecommerce, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom, Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Turkey Vestel Ventures
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Ecommerce, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top